Urea Cream 40%
- Manufacturer
- Akron Pharma Inc.
- Effective date
- 2024-09-25
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 21:13:02
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Urea 40%
Rx Only
For topical use only.
Not for ophthalmic use.
SPL UNCLASSIFIED SECTION
Description
Each gram contains 400 mg of urea in a vehicle consisting of:
cetyl alcohol, glycerin monostearate, phosphomer X-polymer, mineral oil, propylene glycol, purified water, trolamine 99%, white petrolatum, xanthan gum.
CLINICAL PHARMACOLOGY SECTION
Clinical Pharmacology
Urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.
PHARMACOKINETICS SECTION
Pharmacokinetics
The mechanism of action of topically applied urea is not yet known.
INDICATIONS & USAGE SECTION
Indications and Usage
For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eshar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.
CONTRAINDICATIONS SECTION
Contraindications
Known hypersensitivity to any of the listed ingredients.
WARNINGS SECTION
Warnings
For topical use only. Avoid contact with eyes, lips or mucous membranes.
KEEP OUT OF REACH OF CHILDREN.
PRECAUTIONS SECTION
Precautions
FOR EXTERNAL USE ONLY.
NOT FOR OPHTHALMIC USE. Avoid contact with eyes, lips and mucous membranes.
PREGNANCY SECTION
PREGNANACY
Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, Urea 40% should be given to a pregnant woman only if clearly needed.
NURSING MOTHERS SECTION
NURSING MOTHERS
It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Urea 40% is administered to a nursing woman.
ADVERSE REACTIONS SECTION
Adverse Reactions
Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the medication.
To report a serious adverse event or obtain product information, call 1-877-255-6999.
DOSAGE & ADMINISTRATION SECTION
Dosage and Administration
Apply Urea 40% to affected skin twice per day, or as directed by your physician. Rub in until completely absorbed.
Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.
All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each person's professional opinion and knowledge, upon evaluation of the active ingredients, excipients, inactive ingredients and chemical information provided herein.
HOW SUPPLIED SECTION
How Supplied
Urea 40% Cream 1 oz.(28.35 g): NDC 71399-8456-1; Urea 40% Cream 3 oz.(85 g): NDC NDC 71399-8456-3; Urea 40% Cream 7 oz.(198.45 g): NDC NDC 71399-8456-7
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Protect from freezing and excessive heat. Keep bottle tightly closed.
Manufactured for:
Akron Pharma Inc.,
Fairfield, NJ-07004
www.akronpharma.com
Manufactured In USA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71399-8456-1 | 2023-04-03 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
| 71399-8456-3 | 2023-04-03 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
| 71399-8456-7 | 2023-04-03 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
| 71399-8456-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
| 71399-8456-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
| 71399-8456-7 | 2023-01-30 | C162847 | 48780-1 | f386c64a-085e-0266-e053-dadaa90a7c1a | Urea Cream 40% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71399-8456-1 | Urea Cream 40% | 28.35 g in 1 BOTTLE | CREAM | 28.35 | 3 | |
| 71399-8456-3 | Urea Cream 40% | 85 g in 1 BOTTLE | CREAM | 85 | 3 | |
| 71399-8456-7 | Urea Cream 40% | 198.45 g in 1 BOTTLE | CREAM | 198.45 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71399-8456 | UREA CREAM 40% (UREA) CREAM [AKRON PHARMA INC.] | 3 | Current NDC, Legacy NDC, 3 package rows | 20240927_0ce643e9-cf13-4b51-8ffd-8d5636d73e51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71399-8456-1 | GM - Gram | 71399-8456 | c1d155ab-0fbe-42dd-bf35-011a5c741e97 | 1 | 2022-01-06 |
| 71399-8456-3 | GM - Gram | 71399-8456 | e72028ad-b9a6-48c5-980f-e1597ea343b7 | 1 | 2022-01-06 |
| 71399-8456-7 | GM - Gram | 71399-8456 | 84ee9962-d0c4-48bb-80d8-9765df285947 | 1 | 2022-01-06 |
Products#
Every source-derived product name is available through these pages.
- Urea Cream 40%
- Urea
- CETYL ALCOHOL
- GLYCERYL MONOSTEARATE
- CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
- MINERAL OIL
- PROPYLENE GLYCOL
- WATER
- TROLAMINE
- WHITE PETROLATUM
- XANTHAN GUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71399-8456 | 71399-8456-1, 71399-8456-3, 71399-8456-7 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| UREA | 8W8T17847W | ACTIB |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| TROLAMINE | 9O3K93S3TK | IACT |
| WHITE PETROLATUM | B6E5W8RQJ4 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Urea Cream 40% | UREA | Akron Pharma Inc. | 0ce643e9-cf13-4b51-8ffd-8d5636d73e51 | 2024-09-25 | Warnings, Adverse reactions | 71399-8456-1 71399-8456-3 71399-8456-7 71399-8456 71399845601 71399845607 71399845603 6153c0bc-1246-4396-a26d-cd066b909ef5 0ce643e9-cf13-4b51-8ffd-8d5636d73e51 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



